Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Exercise and Fitness Guide
 Diet & Fitness Q&A
 Food Guide
 Diet Reviews
 Fitness and Family
Featured Conditions
 Diet & Exercise
 Food & Fitness
 High Blood Pressure
 Cholesterol
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Obesity, Insulin Level Impact Prostate Cancer Survival


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Addison's Disease
Adenocarcinoma of the Lung and Brain Metastases
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
Diabetes
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Actos
Amaryl
Avandamet
More...

Related News Articles
 border=
New Drug May Work Better Against Chemo Side Effects
Hormone Therapy May Cut Colorectal Cancer Risk
Caring Through Sharing -- Life Changing Stories
Gene Predicts Childhood Leukemia Relapse
More...


Page:  << Prev | 1 | 2

Overweight men (those with a BMI of 25 to 29) had a 47 percent higher risk of dying from prostate cancer, while obese men (BMI of 30 or over) were more than two-and-a-half times more likely to die of the disease, compared with men of healthy weight (BMI under 25).

Men with the highest C-peptide concentrations also had more than double the risk of dying from their cancer compared with men with the lowest levels, the study found.

Finally, men who had a BMI of more than 25 and high C-peptide concentrations had quadruple the risk of dying from their cancer compared with men who had lower BMIs and lower C-peptide levels, the researchers reported.

Text Continues Below



"This suggests that there may be a whole new story to tell, whereby not just androgens have something to do with cancer behavior, but also insulin," Pollak said.

The insulin hormone may be latching onto insulin receptors located on prostate cancer cells, he speculated.

Some pharmaceutical companies are already testing drug candidates that target insulin signaling, Pollak added.

And the findings could have broader implications for other cancers, said study lead author Dr. Jing Ma, of Harvard University's Channing Laboratory.

"The simple things are still the important things. Don't drink, don't smoke, exercise, and eat well," said Dr. Ganesh Palapattu, assistant professor of urology, pathology and oncology at the University of Rochester School of Medicine. "This is yet another piece of evidence suggesting that obesity is not a good thing for many reasons."

"Obesity is the second leading cause of cancer death in this country next to tobacco," emphasized Dr. Jay Brooks, chief of hematology/oncology at Ochsner Health System in Baton Rouge, La. "Two years ago, I would never have told my patients that obesity is increasing their risk of death from cancer. Today, I do."

More information

There's more on prostate cancer at the U.S. National Cancer Institute.

Page:  << Prev | 1 | 2

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 10/6/2008

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Michael Pollak, M.D., professor, oncology, McGill University, Montreal, Quebec, Canada; Jing Ma, M.D., Ph.D., Channing Laboratory, Harvard University, Boston; Jay Brooks, M.D., chief, hematology/oncology, Ochsner Health System, Baton Rouge, La.; Ganesh Palapattu, M.D., assistant professor, urology, pathology and oncology, University of Rochester School of Medicine, N.Y.; Nov. 2008, The Lancet Oncology


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.